Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT
Saved in:
| Main Authors | , , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
05.09.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT |
|---|---|
| AbstractList | The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT |
| Author | DRESCHER, KARLA MEZLER, MARIO MAYRER, MATTHIAS HAUPT, ANDREAS WERNET, WOLFGANG BRAJE, WILFRIED LANGE, UDO UNGER, LILIANE TURNER, SEAN COLM WICKE, KARSTEN |
| Author_xml | – fullname: TURNER, SEAN COLM – fullname: WICKE, KARSTEN – fullname: BRAJE, WILFRIED – fullname: HAUPT, ANDREAS – fullname: LANGE, UDO – fullname: DRESCHER, KARLA – fullname: UNGER, LILIANE – fullname: WERNET, WOLFGANG – fullname: MEZLER, MARIO – fullname: MAYRER, MATTHIAS |
| BookMark | eNqNzL0KwjAUhuEMOvh3D2dwLUikpasVpatQ5xKbUw2k54Tk5P7N4AU4fcP78G3Viphwo-iRHbF3hDDxEjiTTZCyE_PyCDNHkIhGHL3BusTRYkwgHyMQMQUmC8KwsM2-ICbguVSEhJGFyRHUVT80BU8YhONerWfjEx5-u1PH-2249hUGHsuhmZBQxstTn06tbuum1l2nz3-yLwlBRew |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2008285652BB2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2008285652BB23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:55:32 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2008285652BB23 |
| Notes | Application Number: AU20080285652 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130905&DB=EPODOC&CC=AU&NR=2008285652B2 |
| ParticipantIDs | epo_espacenet_AU2008285652BB2 |
| PublicationCentury | 2000 |
| PublicationDate | 20130905 |
| PublicationDateYYYYMMDD | 2013-09-05 |
| PublicationDate_xml | – month: 09 year: 2013 text: 20130905 day: 05 |
| PublicationDecade | 2010 |
| PublicationYear | 2013 |
| RelatedCompanies | ABBVIE DEUTSCHLAND GMBH & CO. KG |
| RelatedCompanies_xml | – name: ABBVIE DEUTSCHLAND GMBH & CO. KG |
| Score | 2.902609 |
| Snippet | The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130905&DB=EPODOC&locale=&CC=AU&NR=2008285652B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bT8IwFG4IGvVNUeMN0weyt0Yo28oeiHEbhJhw0YDhjawXIwmuhJX49z1thvKkb0u7NF27c2u_cz6EGpRJ0I1MECFZRHyatQmnUUgEF0oocFGktLnDw1E4mPnP82BeQatdLoyrE_rliiOCRAmQd-P09fr3ECt12MrigS-hST_2p93UK6NjUMhRM_DSuNubjNNx4iUJRJLe6NVd89MOeC80BoV9AI40s_LQe4ttXsp636j0T9HhBMbLzRmqqLyGjpMd91oNHQ3LK294LKWvOEf5y3aZW5IdhS0S3BIiFbjYQnTPVwqD94kdbByMEZZlUc0Cm4_M4I1DwkpsNP7UsmTswvodehWGn1AbeyqLAzKYhvCyhbrozQVq9HvTZEBg4oufdVo8zfa-MqbtS1TNda6uEJaMU-VHGctExw9Ui3cY7ErYCmUY-UGbXaP6n0Pd_NN_i06oo4mISDO4Q1Wz2ao6GGvD790afwN2DZpG |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NT8IwFH8haMSbosYvtAey2yKUbWUHYtwGmcqXZhhuhK01kuBGWIn_vq_NUE56W9ql6dq9r_b33g-gThlH3cgSM-HMNS06b5kxdR0ziRORCHRROFe5w4OhE06sp6k9LcFymwuj64R-6eKIKFEJyrvU-nr1e4gVaGxlfhcvsCm770WdwCiiY1TIbsM2Aq_THY-CkW_4PkaSxvBVX_PTNnov1EOFvYdONlPy0H3zVF7Kateo9I5gf4zjpfIYSiKtQsXfcq9V4WBQXHnjYyF9-QmkL5tFqkh2BFFIcEWIlJN8g9F9vBQEvU-iYeNojAgvimrmRH7MJVlrJCwnMiOfGS8Yu0j2jr2C4E-YSXUqS2wzjBx8WUFdsvUp1HvdyA9NnPjsZ51mD5Odr_Ro6wzKaZaKcyCcxVRY7pzNk7Zli2bcZrgrTtPhjmvZLXYBtT-Huvyn_xYqYTToz_qPw-crOKSaMsI1G_Y1lOV6I2pouGV8o9f7G9-gnTk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Quinoline+compounds+suitable+for+treating+disorders+that+respond+to+modulation+of+the+serotonin+5-HT6+receptor&rft.inventor=TURNER%2C+SEAN+COLM&rft.inventor=WICKE%2C+KARSTEN&rft.inventor=BRAJE%2C+WILFRIED&rft.inventor=HAUPT%2C+ANDREAS&rft.inventor=LANGE%2C+UDO&rft.inventor=DRESCHER%2C+KARLA&rft.inventor=UNGER%2C+LILIANE&rft.inventor=WERNET%2C+WOLFGANG&rft.inventor=MEZLER%2C+MARIO&rft.inventor=MAYRER%2C+MATTHIAS&rft.date=2013-09-05&rft.externalDBID=B2&rft.externalDocID=AU2008285652BB2 |